O6-methylguanine-DNA-methyltransferase thus confers resistance to certain alkylating antitumour agents such as the methylating drugs DTIC and temozolomide (TMZ) in cultured tumour cells (Pegg, 1990, 2000), including melanoma cells (Lage et al, 1999). This evidence concerns the gene MGMT and melanoma.